Industry News

Aug 09, 2013
By BioPharm International Editors
FDA receives adverse event reports related to calcium gluconate infusions.
Aug 08, 2013
By BioPharm International Editors
Gallus Biopharmaceuticals has signed a development and manufacturing supply agreement with Genzyme.
Aug 08, 2013
By BioPharm International Editors
The companies sign a nonexclusive research license agreement, giving Sorrento's access to Lonza's GS Xceed Gene Expression System.
Aug 08, 2013
By BioPharm International Editors
ScinoPharm Changshu Pharmaceuticals and Sundia MediTech form an alliance for contract research and manufacturing services in mainland China.
Aug 07, 2013
By BioPharm International Editors
Lyophilization Services of New England (LSNE) received a Certificate of GMP Compliance for its New Hampshire facility.
Aug 07, 2013
By BioPharm International Editors
The companies initially focused on five biosimilar products.
Aug 07, 2013
By BioPharm International Editors
The guidance describes a risk-based approach to monitoring of clinical trials.
Aug 06, 2013
By BioPharm International Editors
A proposed new guideline provides a global policy for limiting metal impurities qualitatively and quantitatively in drug products and ingredients.
Aug 06, 2013
By BioPharm International Editors
The licensed cell line combines BioWa's engineered glycosylation Potelligent Technology with Lonza's GS Gene Expression System.
Aug 02, 2013
By BioPharm International Editors
EMA releases concept paper on development of product-specific guidance on demonstration of bioequivalence.
native1_300x100
lorem ipsum